Our findings suggest a model that the antiviral host response to HIV/SIV infection through GCN2-ATF4 signaling may be exploited by the virus to activate its transcription and expression, may be highly relevant during the early stages of infection in vivo, and may serve as an excellent target for prevention of viral dissemination. Here, ATF4 is linked to infection.